SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-19-039617
Filing Date
2019-08-13
Accepted
2019-08-13 17:08:12
Documents
1
Group Members
BAKER BROS. ADVISORS (GP) LLCFELIX J. BAKERJULIAN C. BAKER

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tv527581_sc13da.htm SC 13D/A 109091
  Complete submission text file 0001144204-19-039617.txt   110999
Mailing Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014 2123395600
BAKER BROS. ADVISORS LP (Filed by) CIK: 0001263508 (see all company filings)

IRS No.: 134093645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 401 TERRY AVENUE NORTH SEATTLE WA 98109
Business Address 401 TERRY AVENUE NORTH SEATTLE WA 98109 206-732-2133
Neoleukin Therapeutics, Inc. (Subject) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88050 | Film No.: 191021640
SIC: 2834 Pharmaceutical Preparations